ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,873,908 | -3.2% | 104,396 | +9.5% | 0.00% | 0.0% |
| Q2 2023 | $1,935,462 | +13.3% | 95,296 | +1.7% | 0.00% | 0.0% |
| Q1 2023 | $1,709,015 | -20.9% | 93,696 | -10.3% | 0.00% | -50.0% |
| Q4 2022 | $2,160,977 | -19.0% | 104,496 | +2.5% | 0.00% | 0.0% |
| Q3 2022 | $2,668,000 | +4.8% | 101,996 | +1.5% | 0.00% | 0.0% |
| Q2 2022 | $2,547,000 | -11.6% | 100,496 | +10.1% | 0.00% | 0.0% |
| Q1 2022 | $2,881,000 | -17.7% | 91,296 | +5.5% | 0.00% | 0.0% |
| Q4 2021 | $3,500,000 | +16.9% | 86,496 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $2,995,000 | +27.0% | 85,896 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $2,359,000 | -13.0% | 85,896 | -11.0% | 0.00% | -50.0% |
| Q1 2021 | $2,710,000 | +9.5% | 96,496 | +1.2% | 0.00% | 0.0% |
| Q4 2020 | $2,476,000 | +72.4% | 95,396 | +13.8% | 0.00% | +100.0% |
| Q3 2020 | $1,436,000 | -29.6% | 83,796 | +1.6% | 0.00% | -50.0% |
| Q2 2020 | $2,041,000 | +230.3% | 82,496 | +85.4% | 0.00% | +100.0% |
| Q1 2020 | $618,000 | +41.7% | 44,500 | +3.0% | 0.00% | – |
| Q4 2019 | $436,000 | +10.9% | 43,200 | 0.0% | 0.00% | – |
| Q3 2019 | $393,000 | +14.6% | 43,200 | 0.0% | 0.00% | – |
| Q2 2019 | $343,000 | -36.5% | 43,200 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $540,000 | +16.1% | 43,200 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $465,000 | – | 43,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |